Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on March 9, 2026

Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education
Server-Class Ethernet NIC Revenues Have Doubled in Just Two Years, Reports Crehan Research
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris 
CenTrak Showcases Next Generation of AI-Enhanced Location Intelligence Platform at HIMSS 2026
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
Cloudcure Launches Companion App to Close Clinical Adherence Gap in Metabolic Health
SafeSpace Global Opens Nashville Office, Builds Operational Infrastructure to Support Revenue Growth
Joint Commission names new members to boards of directors for Joint Commission Resources and National Quality Forum
AsymBio Completes its Dual-Site, One-Center Network with Fengxian Commercial Manufacturing Site Operational, Enhancing End-to-End Biologics CDMO Capabilities
Cellhub Introduces Cellhub Managed Services at HIMSS to Power its “Hospitals Without Walls” Virtual Care Initiative
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients
SRx Health Solutions Launches EventHorizonIQ Subscription for Individual and Institutional Traders
First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics
Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301’s Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Share this page:

Sign up for:

Healthy Living South Dakota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.